What question did this study set out to answer?

To evaluate whether a one-time gene administration of myostatin inhibitors can produce sustained enhancements in skeletal muscle mass and strength across normal, dystrophic, and aged mouse models.

March 11, 2008Proceedings of the National Academy of SciencesOpen Access

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

View Full Paper

Ask AI

Bookmark

Why the study?

Does one-time gene administration of myostatin-inhibitor-proteins improve muscle mass and strength in normal and dystrophic mouse models?

Key Points

To evaluate whether a one-time gene administration of myostatin inhibitors can produce sustained enhancements in skeletal muscle mass and strength across normal, dystrophic, and aged mouse models.
Administered a single dose of gene therapy encoding myostatin-inhibitor proteins into normal and dystrophic mouse models.
Treated cohorts across different age groups, including aged animals, and evaluated muscle mass and functional outcomes over a follow-up period exceeding two years.
A single administration sustained significant enhancements in skeletal muscle mass and force generation for more than two years.
Robust improvements in muscle mass and strength occurred even when the vector was delivered to aged animals.

Structured PICO

Does one-time gene administration of myostatin-inhibitor-proteins improve muscle mass and strength in normal and dystrophic mouse models?

Population

normal and dystrophic mouse models, including aged animals

Intervention

one-time gene administration of myostatin-inhibitor-proteins

Outcome

muscle mass and strengthsurrogate

A single gene administration of myostatin inhibitors provides long-term enhancement of muscle mass and strength in mouse models, suggesting a potential therapeutic strategy for human muscle diseases.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Hypothesis-generating for durable myostatin gene therapy in muscle disease; leaves open human translation and safety.

Cite This Study

Haidet et al. (2008) studied this question.

synapsesocial.com/papers/6a757d12ef3d015f2ddd74a8 https://doi.org/10.1073/pnas.0709144105

View Full Paper

Ask AI

Bookmark

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider